BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

811 related articles for article (PubMed ID: 25880576)

  • 1. Pretreatment of mesenchymal stem cells with angiotensin II enhances paracrine effects, angiogenesis, gap junction formation and therapeutic efficacy for myocardial infarction.
    Liu C; Fan Y; Zhou L; Zhu HY; Song YC; Hu L; Wang Y; Li QP
    Int J Cardiol; 2015 Jun; 188():22-32. PubMed ID: 25880576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium.
    Suresh SC; Selvaraju V; Thirunavukkarasu M; Goldman JW; Husain A; Alexander Palesty J; Sanchez JA; McFadden DW; Maulik N
    Int J Cardiol; 2015 Dec; 201():517-28. PubMed ID: 26322599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cx43 in mesenchymal stem cells promotes angiogenesis of the infarcted heart independent of gap junctions.
    Wang DG; Zhang FX; Chen ML; Zhu HJ; Yang B; Cao KJ
    Mol Med Rep; 2014 Apr; 9(4):1095-102. PubMed ID: 24481773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MSCs transfected with hepatocyte growth factor or vascular endothelial growth factor improve cardiac function in the infarcted porcine heart by increasing angiogenesis and reducing fibrosis.
    Lu F; Zhao X; Wu J; Cui Y; Mao Y; Chen K; Yuan Y; Gong D; Xu Z; Huang S
    Int J Cardiol; 2013 Sep; 167(6):2524-32. PubMed ID: 22981278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction.
    Yang J; Zhou W; Zheng W; Ma Y; Lin L; Tang T; Liu J; Yu J; Zhou X; Hu J
    Cardiology; 2007; 107(1):17-29. PubMed ID: 16741354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of myocardial transplantation of mesenchymal stem cells transfected with vascular endothelial factor gene on improvement of heart function and angiogenesis after myocardial infarction: experiment with rats].
    Yang JF; Zhou WW; Tang T; Yu JF; Zhou XM; Hu JG
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(15):1027-34. PubMed ID: 16784704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-Kit Positive Cardiac Stem Cells and Bone Marrow-Derived Mesenchymal Stem Cells Synergistically Enhance Angiogenesis and Improve Cardiac Function After Myocardial Infarction in a Paracrine Manner.
    Bao L; Meng Q; Li Y; Deng S; Yu Z; Liu Z; Zhang L; Fan H
    J Card Fail; 2017 May; 23(5):403-415. PubMed ID: 28284757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron oxide nanoparticle-mediated development of cellular gap junction crosstalk to improve mesenchymal stem cells' therapeutic efficacy for myocardial infarction.
    Han J; Kim B; Shin JY; Ryu S; Noh M; Woo J; Park JS; Lee Y; Lee N; Hyeon T; Choi D; Kim BS
    ACS Nano; 2015 Mar; 9(3):2805-19. PubMed ID: 25688594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats.
    Tang J; Wang J; Yang J; Kong X; Zheng F; Guo L; Zhang L; Huang Y
    Eur J Cardiothorac Surg; 2009 Oct; 36(4):644-50. PubMed ID: 19524448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction.
    Hahn JY; Cho HJ; Kang HJ; Kim TS; Kim MH; Chung JH; Bae JW; Oh BH; Park YB; Kim HS
    J Am Coll Cardiol; 2008 Mar; 51(9):933-43. PubMed ID: 18308163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic induction of pro-angiogenic milieu after transplantation of marrow-derived mesenchymal stem cells in experimental myocardial infarction.
    Rahbarghazi R; Nassiri SM; Ahmadi SH; Mohammadi E; Rabbani S; Araghi A; Hosseinkhani H
    Int J Cardiol; 2014 May; 173(3):453-66. PubMed ID: 24679689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human umbilical cord mesenchymal stem cells pretreated with Angiotensin-II attenuate pancreas injury of rats with severe acute pancreatitis.
    Yang J; Su J; Xi SS; Ke XF; Zhu Y; Lin HP; Zeng XK; Liu BW; Zhu ML; Dai WY; Hu W
    Biomed Pharmacother; 2019 Sep; 117():109052. PubMed ID: 31176170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion.
    Tang J; Xie Q; Pan G; Wang J; Wang M
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):353-61. PubMed ID: 16829080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of transplanted mesenchymal stem cells from rats of different ages on the improvement of heart function after acute myocardial infarction.
    Wang YQ; Wang M; Zhang P; Song JJ; Li YP; Hou SH; Huang CX
    Chin Med J (Engl); 2008 Nov; 121(22):2290-8. PubMed ID: 19080335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-377 regulates mesenchymal stem cell-induced angiogenesis in ischemic hearts by targeting VEGF.
    Wen Z; Huang W; Feng Y; Cai W; Wang Y; Wang X; Liang J; Wani M; Chen J; Zhu P; Chen JM; Millard RW; Fan GC; Wang Y
    PLoS One; 2014; 9(9):e104666. PubMed ID: 25251394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia pretreatment of bone marrow mesenchymal stem cells facilitates angiogenesis by improving the function of endothelial cells in diabetic rats with lower ischemia.
    Liu J; Hao H; Xia L; Ti D; Huang H; Dong L; Tong C; Hou Q; Zhao Y; Liu H; Fu X; Han W
    PLoS One; 2015; 10(5):e0126715. PubMed ID: 25996677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell transplantation into ischemic myocardium using mesenchymal stem cells transfected by vascular endothelial growth factor.
    Hua P; Tao J; Liu JY; Yang SR
    Int J Clin Exp Pathol; 2014; 7(11):7782-8. PubMed ID: 25550816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA H19.
    Huang P; Wang L; Li Q; Tian X; Xu J; Xu J; Xiong Y; Chen G; Qian H; Jin C; Yu Y; Cheng K; Qian L; Yang Y
    Cardiovasc Res; 2020 Feb; 116(2):353-367. PubMed ID: 31119268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AKT-modified autologous intracoronary mesenchymal stem cells prevent remodeling and repair in swine infarcted myocardium.
    Yu YS; Shen ZY; Ye WX; Huang HY; Hua F; Chen YH; Chen K; Lao WJ; Tao L
    Chin Med J (Engl); 2010 Jul; 123(13):1702-8. PubMed ID: 20819633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the effects of MSCs and CD34+ cell therapy in a rat model of myocardial infarction.
    Shalaby SM; El-Shal AS; Zidan HE; Mazen NF; Abd El-Haleem MR; Abd El Motteleb DM
    IUBMB Life; 2016 May; 68(5):343-54. PubMed ID: 26949188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.